Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-051720
Filing Date
2020-09-23
Accepted
2020-09-23 19:35:52
Documents
1
Period of Report
2020-08-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3969
  Complete submission text file 0001209191-20-051720.txt   5458
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Issuer) CIK: 0001674930 (see all company filings)

EIN.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O FULGENT GENETICS, INC. 4978 SANTA ANITA AVE., SUITE 205 TEMPLE CITY CA 91780
Business Address
Xie Jian (Reporting) CIK: 0001819718 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37894 | Film No.: 201193190